Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/29241
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2022-10-27T11:02:40Z | - |
dc.date.available | 2022-10-27T11:02:40Z | - |
dc.date.issued | 2016-12 | - |
dc.identifier.citation | Ergönül, O. vd. (2016). "Healthcare-associated Gram-negative bloodstream infections: Antibiotic resistance and predictors of mortality". Journal of Hospital Infection, 94(4), 381-385. | en_US |
dc.identifier.issn | 0195-6701 | - |
dc.identifier.issn | 1532-2939 | - |
dc.identifier.uri | https://doi.org/10.1016/j.jhin.2016.08.012 | - |
dc.identifier.uri | https://www.sciencedirect.com/science/article/pii/S0195670116303280 | - |
dc.identifier.uri | http://hdl.handle.net/11452/29241 | - |
dc.description | Çalışmada 28 yazar bulunmaktadır. Bu yazarlardan sadece Bursa Uludağ Üniversitesi mensubu yazarların girişleri yapılmıştır. | tr_TR |
dc.description.abstract | This article describes the prevalence of antibiotic resistance and predictors of mortality for healthcare-associated (HA) Gram-negative bloodstream infections (GN-BSI). In total, 831 cases of HA GN-BSI from 17 intensive care units in different centres in Turkey were included; the all-cause mortality rate was 44%. Carbapenem resistance in Klebsiella pneumoniae was 38%, and the colistin resistance rate was 6%. Multi-variate analysis showed that age > 70 years [odds ratio (OR) 2, 95% confidence interval (CI) 1.22-3.51], central venous catheter use (OR 2.1, 95% CI 1.09-4.07), ventilator- associated pneumonia (OR 1.9, 95% CI 1.1-3.16), carbapenem resistance (OR 1.8, 95% CI 1.11-2.95) and APACHE II score (OR 1.1, 95% CI 1.07-1.13) were significantly associated with mortality. | en_US |
dc.language.iso | en | en_US |
dc.publisher | W B Saunders | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Public, environmental & occupational health | en_US |
dc.subject | lthInfectious diseases | en_US |
dc.subject | Bloodstream | en_US |
dc.subject | Gram-negative | en_US |
dc.subject | Healthcare | en_US |
dc.subject | Klebsiella-pneumoniae | en_US |
dc.subject | Outcomes | en_US |
dc.subject | Impactenterobacteriaceae | en_US |
dc.subject | Epidemiology | en_US |
dc.subject | Surveillance | en_US |
dc.subject | Bacteremia | en_US |
dc.subject | Program | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Aged | en_US |
dc.subject.mesh | Bacteremia | en_US |
dc.subject.mesh | Cross infection | en_US |
dc.subject.mesh | Drug resistance, bacterial | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Gram-negative bacteria | en_US |
dc.subject.mesh | Gram-negative bacterial infections | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Intensive care units | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Middle aged | en_US |
dc.subject.mesh | Prevalence | en_US |
dc.subject.mesh | Prognosis | en_US |
dc.subject.mesh | Retrospective studies | en_US |
dc.subject.mesh | Risk factors | en_US |
dc.subject.mesh | Survival analysis | en_US |
dc.subject.mesh | Turkey | en_US |
dc.title | Healthcare-associated Gram-negative bloodstream infections: Antibiotic resistance and predictors of mortality | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000389233700014 | tr_TR |
dc.identifier.scopus | 2-s2.0-84996899090 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Anabilim Dalı. | tr_TR |
dc.contributor.orcid | 0000-0002-3894-1231 | tr_TR |
dc.identifier.startpage | 381 | tr_TR |
dc.identifier.endpage | 385 | tr_TR |
dc.identifier.volume | 94 | tr_TR |
dc.identifier.issue | 4 | tr_TR |
dc.relation.journal | Journal of Hospital Infection | en_US |
dc.contributor.buuauthor | Yılmaz, Emel | - |
dc.contributor.buuauthor | Akalın, Halis | - |
dc.contributor.researcherid | AAU-8952-2020 | tr_TR |
dc.relation.collaboration | Yurt içi | tr_TR |
dc.relation.collaboration | Sanayi | tr_TR |
dc.identifier.pubmed | 27717604 | tr_TR |
dc.subject.wos | Public, environmental & occupational health | en_US |
dc.subject.wos | Infectious diseases | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | PubMed | en_US |
dc.wos.quartile | Q2 | en_US |
dc.contributor.scopusid | 22037135100 | tr_TR |
dc.contributor.scopusid | 57207553671 | tr_TR |
dc.subject.scopus | Beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Klebsiella Pneumoniae | en_US |
dc.subject.emtree | Aminoglycoside antibiotic agent | en_US |
dc.subject.emtree | Antibiotic agent | en_US |
dc.subject.emtree | Carbapenem | en_US |
dc.subject.emtree | Cephalosporin | en_US |
dc.subject.emtree | Colistin | en_US |
dc.subject.emtree | Piperacillin plus tazobactam | en_US |
dc.subject.emtree | Quinoline derived antiinfective agent | en_US |
dc.subject.emtree | Acinetobacter baumannii | en_US |
dc.subject.emtree | Adult | en_US |
dc.subject.emtree | APACHE | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Bloodstream infection | en_US |
dc.subject.emtree | Cause of death | en_US |
dc.subject.emtree | Central venous catheter | en_US |
dc.subject.emtree | Controlled clinical trial | en_US |
dc.subject.emtree | Controlled study | en_US |
dc.subject.emtree | Enterobacter cloacae | en_US |
dc.subject.emtree | Escherichia coli | en_US |
dc.subject.emtree | Female | en_US |
dc.subject.emtree | Gram negative infection | en_US |
dc.subject.emtree | Healthcare associated infection | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Intensive care unit | en_US |
dc.subject.emtree | Klebsiella pneumoniae | en_US |
dc.subject.emtree | Major clinical study | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Mortality | en_US |
dc.subject.emtree | Mortality rate | en_US |
dc.subject.emtree | Multicenter study | en_US |
dc.subject.emtree | Nonhuman | en_US |
dc.subject.emtree | Pseudomonas aeruginosa | en_US |
dc.subject.emtree | Retrospective study | en_US |
dc.subject.emtree | Turkey (republic) | en_US |
dc.subject.emtree | Ventilator associated pneumonia | en_US |
dc.subject.emtree | Aged | en_US |
dc.subject.emtree | Antibiotic resistance | en_US |
dc.subject.emtree | Bacteremia | en_US |
dc.subject.emtree | Classification | en_US |
dc.subject.emtree | Clinical trial | en_US |
dc.subject.emtree | Cross infection | en_US |
dc.subject.emtree | Drug effects | en_US |
dc.subject.emtree | Gram negative bacterium | en_US |
dc.subject.emtree | Gram-negative bacterial infections | en_US |
dc.subject.emtree | Isolation and purification | en_US |
dc.subject.emtree | Microbiology | en_US |
dc.subject.emtree | Middle aged | en_US |
dc.subject.emtree | Prevalence | en_US |
dc.subject.emtree | Prognosis | en_US |
dc.subject.emtree | Risk factor | en_US |
dc.subject.emtree | Survival analysis | en_US |
dc.subject.emtree | Turkey | en_US |
Appears in Collections: | Scopus Web of Science |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.